Neovasc Announces First Patient Enrollment in COSIMA Trial
10. Mai 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled...
Neovasc Announces First Quarter 2021 Financial Results
06. Mai 2021 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today reported financial results for the first...
Neovasc Provides Reducer Reimbursement Progress Update
28. April 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced progress towards its value creation...
Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021
27. April 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ, TSX: NVCN) will report financial results for the first quarter ended March 31, 2021 on...
Neovasc Comments on EuroIntervention Article
19. April 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the journal EuroIntervention has...
Neovasc Provides Tiara TA Update
16. April 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today announced that the Tiara Transapical system...
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
11. März 2021 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today reported financial results for the fourth...
Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021
04. März 2021 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (NASDAQ, TSX: NVCN) will report results for the fourth quarter and fiscal year ended December 31, 2020...
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
03. März 2021 16:30 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the 2021 H.C....
Neovasc Comments on Clinical Cardiology Journal Publication
02. März 2021 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the journal Clinical Cardiology...